81 related articles for article (PubMed ID: 20079783)
21. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.
Csaba N; Köping-Höggård M; Alonso MJ
Int J Pharm; 2009 Dec; 382(1-2):205-14. PubMed ID: 19660537
[TBL] [Abstract][Full Text] [Related]
22. Sequence-related off-target effect of Dz13 against human tumor cells and safety in adult and fetal mice following systemic administration.
Dass CR; Choong PF
Oligonucleotides; 2010 Apr; 20(2):51-60. PubMed ID: 20148692
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.
Borges O; Tavares J; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
Eur J Pharm Sci; 2007 Dec; 32(4-5):278-90. PubMed ID: 17884394
[TBL] [Abstract][Full Text] [Related]
24. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles.
Tiyaboonchai W; Limpeanchob N
Int J Pharm; 2007 Feb; 329(1-2):142-9. PubMed ID: 17000065
[TBL] [Abstract][Full Text] [Related]
25. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes.
Densmore CL; Kleinerman ES; Gautam A; Jia SF; Xu B; Worth LL; Waldrep JC; Fung YK; T'Ang A; Knight V
Cancer Gene Ther; 2001 Sep; 8(9):619-27. PubMed ID: 11593330
[TBL] [Abstract][Full Text] [Related]
26. Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy.
Sun Y; Chen ZL; Yang XX; Huang P; Zhou XP; Du XX
Nanotechnology; 2009 Apr; 20(13):135102. PubMed ID: 19420486
[TBL] [Abstract][Full Text] [Related]
27. Dz13 induces a cytotoxic stress response with upregulation of E2F1 in tumor cells metastasizing to or from bone.
Dass CR; Tan ML; Galloway SJ; Choong PF
Oligonucleotides; 2010 Apr; 20(2):79-91. PubMed ID: 20406096
[TBL] [Abstract][Full Text] [Related]
28. Preparation and evaluation of anti-Helicobacter pylori efficacy of chitosan nanoparticles in vitro and in vivo.
Luo D; Guo J; Wang F; Sun J; Li G; Cheng X; Chang M; Yan X
J Biomater Sci Polym Ed; 2009; 20(11):1587-96. PubMed ID: 19619399
[TBL] [Abstract][Full Text] [Related]
29. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
30. Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA.
Wang SL; Yao HH; Guo LL; Dong L; Li SG; Gu YP; Qin ZH
Cancer Genet Cytogenet; 2009 Apr; 190(1):8-14. PubMed ID: 19264227
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.
Bivas-Benita M; van Meijgaarden KE; Franken KL; Junginger HE; Borchard G; Ottenhoff TH; Geluk A
Vaccine; 2004 Apr; 22(13-14):1609-15. PubMed ID: 15068842
[TBL] [Abstract][Full Text] [Related]
33. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
[TBL] [Abstract][Full Text] [Related]
34. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
[TBL] [Abstract][Full Text] [Related]
35. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
Price JT; Quinn JM; Sims NA; Vieusseux J; Waldeck K; Docherty SE; Myers D; Nakamura A; Waltham MC; Gillespie MT; Thompson EW
Cancer Res; 2005 Jun; 65(11):4929-38. PubMed ID: 15930315
[TBL] [Abstract][Full Text] [Related]
36. Dz13, a c-jun DNAzyme, is a potent inducer of caspase-2 activation.
Dass CR; Galloway SJ; Choong PF
Oligonucleotides; 2010 Jun; 20(3):137-46. PubMed ID: 20180631
[TBL] [Abstract][Full Text] [Related]
37. Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy.
Lin YH; Chang CH; Wu YS; Hsu YM; Chiou SF; Chen YJ
Biomaterials; 2009 Jul; 30(19):3332-42. PubMed ID: 19299008
[TBL] [Abstract][Full Text] [Related]
38. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles.
Douglas KL; Piccirillo CA; Tabrizian M
J Control Release; 2006 Oct; 115(3):354-61. PubMed ID: 17045691
[TBL] [Abstract][Full Text] [Related]
39. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery.
Yoo HS; Lee JE; Chung H; Kwon IC; Jeong SY
J Control Release; 2005 Mar; 103(1):235-43. PubMed ID: 15710514
[TBL] [Abstract][Full Text] [Related]
40. In vivo antitumor activity of chitosan nanoparticles.
Qi L; Xu Z
Bioorg Med Chem Lett; 2006 Aug; 16(16):4243-5. PubMed ID: 16759859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]